Case Counts

The Infectious Diseases & Outbreaks Division monitors the incidence and prevalence of communicable, zoonotic, and environmentally-related human diseases. This table summarizes cases reported over the last five years, as well as the cases reported year-to-date this year and last year.

	Cases Reported Year-to-Date*			Totals by Year Reported
Condition	2025	2024	% Change	2024	2023	2022	2021	2020
Acute Flaccid Myelitis	0	0	--	0	0	1	1	0^
Anthrax	0	0	--	0^	0	0	0	0
Arboviral Diseases (excludes Chikungunya virus, Dengue, and Zika virus)	1	0	100.0%	36	32	5	12	10
Babesiosis	0	2	-100.0%	4^	1	0	1	1
Botulism	0	0	--	1	2	2	0	1
Brucellosis	0	0	--	0^	0	0	1	1
Campylobacteriosis	558	511	9.2%	1153	878	813	745	665
Chikungunya virus - travel related, acquired out of state	0	0	--	0	1	0	0	0
Cholera	0	0	--	0	0	0	0	0
Coccidioidomycosis	4	5	-20.0%	10	12	12	13	5
Cryptosporidiosis	66	80	-17.5%	248	213	158	125	138
Cyclosporiasis	2	1	100.0%	30	140	19	6	9
Dengue - travel related, acquired out of state	1	3	-66.7%	11	5	5	1	0
E. coli, shiga toxin-producing (includes O157: H7)	76	81	-6.2%	163	170	159	138	100
Ehrlichiosis/Anaplasmosis	7	6	16.7%	13	5	10	24	12
Hansen's Disease (Leprosy)	1	0	100.0%	0	2	0	0	1
Hemolytic uremic syndrome (HUS)	3	0	300.0%	1	6	10	3	3
Influenza-associated pediatric mortality	2	1	100.0%	1	1	3	0	1
Legionellosis	41	36	13.9%	81	66	65	89	61
Listeriosis	7	4	75.0%	8	16	12	12	14
Lyme disease	11	18	-38.9%	38	34	32	51	15
Malaria - travel related, acquired out of state	0	2	-200.0%	9	11	8	8	2
Novel Influenza A virus infection	0	0	--	0^	0	0	0	0
Paratyphoid Fever	1	1	00.0%	7	0	2	2	1
Plague	0	0	--	0	0	0	0	0^
Primary Amebic Meningoencephalitis (Naegleria fowleri)	0	0	--	0^	0	0	0	0
Q fever	0	0	--	1	2	3	2	0
Rabies, animal	15	13	15.4%	28	38^	45	44	51
Rabies, human	0	0	--	0	0	0	0	0
Salmonellosis	363	351	3.4%	1093	879	996	861	891
Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)	0	0	--	0	0	0	0	0
Shigellosis	62	65	-4.6%	125	100	81	88	346
Smallpox	0	0	--	0	0	0	0	0
Spotted Fever Rickettsiosis	35	31	12.9%	72	81	118	121	90
Trichinellosis (Trichinosis)	0	0	--	0	0	1	0	0
Tularemia	0	0	--	1	1	3	0	1
Typhoid fever	0	0	--	1	2	0	3	1
Vibriosis (non-Cholera)	18	19	-5.3%	54	37	41	34	26
Viral hemorrhagic fever	0	0	--	0^	0	0	0	0
VISA (Staphylococcus aureus, vancomycin-intermediate)	1	0	100.0%	1	1	1	1	0
VRSA (Staphylococcus aureus, vancomycin-resistant)	3	1	200.0%	1	0	0	1	1
Yellow Fever	0	0	--	0	0	0	0	0
Zika virus - travel related, acquired out of state	0	0	--	0	0	0	0	0
Other Investigations	1	2	-50%	2	5	0	1	0
Total	1279	1234	3.6%	3193	2741	2604	2389	2447
NOTE: Counts include finalized investigations among Alabama residents as of July 1, 2025. The Other investigations category includes a variety of conditions or events that have been investigated, but are not reportable in Alabama or do not fall into any other category (e.g., Histoplasmosis, Streptococcal toxic-shock syndrome, Yersiniosis, etc.). To see case counts for conditions investigated by other divisions, please see the following websites: Tuberculosis, Immunizations, Sexually Transmitted Diseases, and HIV/AIDS.
*Through MMWR Week 26 (week ending June 28, 2025), as compared to the same time period in the previous calendar year.
^The case definition was updated this year for this condition.

Page last updated: July 2, 2025